Primary hypercholesterolemia and development of cardiovascular disorders: Cellular and molecular mechanisms involved

Aida Collado1, Elena Domingo1, Laura Piqueras2

  • 1Department of Pharmacology, Faculty of Medicine, University of Valencia, Valencia, Spain; Institute of Health Research INCLIVA, University Clinic Hospital of Valencia, Valencia, Spain.

Insights

Primary hypercholesterolemia, marked by high LDL cholesterol, drives atherosclerosis. Understanding its inflammation and endothelial dysfunction mechanisms can reveal new cardiovascular disease treatments.

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiovascular Medicine

Background:

  • Primary hypercholesterolemia involves elevated low-density lipoproteins (LDL), a key factor in arteriosclerosis.
  • Atherosclerosis underlies most cardiovascular diseases, including myocardial infarction and stroke.
  • Low-grade systemic inflammation and endothelial dysfunction are primary drivers of premature atherosclerosis.

Purpose of the Study:

  • To review cellular and molecular mechanisms of inflammation and endothelial dysfunction in primary hypercholesterolemia.
  • To explore the role of inflammatory mediators, immune cells, and signaling pathways in atherogenesis.
  • To identify potential therapeutic targets for cardiovascular disease progression.

Main Methods:

  • Literature review of current scientific knowledge.
  • Analysis of cellular and molecular mechanisms.
  • Discussion of inflammatory mediators and signaling pathways.

Main Results:

  • Elevated LDL cholesterol contributes to arteriosclerosis.
  • Systemic inflammation and endothelial dysfunction are critical in atherosclerosis development.
  • Leukocyte adhesion to dysfunctional endothelium is a key feature of atherogenesis.

Conclusions:

  • Understanding hypercholesterolemia-linked inflammation and dysfunction is crucial for cardiovascular disease insights.
  • This knowledge may lead to novel therapeutic strategies to slow disease progression.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
99
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
208
Inflammation01:38

Inflammation

Overview
56.4K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
773
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
70
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
521